Affibody-Modified Gd@C-Dots with Efficient Renal Clearance for Enhanced MRI of EGFR Expression in Non-Small-Cell Lung Cancer [Corrigendum]

Wu Y, Li H, Yan Y, et al. Int J Nanomedicine. 2020;15:4691—4703.

The authors have advised due to an error that occurred inadvertently at the time of figure assembly, the MRI images at the 2 hour time point in Figure 6A and the 10 minute time point in Figure 6B on page 4700 are incorrect. The correct Figure 6 is as follows.

Figure 6 MR imaging of renal clearance. (A) Sagittal T1-weighted MR images of Gd@C-dots-Cys-ZEGFR:1907 in animal. (B) Sagittal T1-weighted MR images of Gd@C-dots in animal.

The authors apologize for the errors and advise they do not affect the results and conclusions of the paper.

Read the original article

© 2025 The Author(s). This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, 4.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.